Table 1 Patient Characteristics
From: The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia
Characteristic | De novo AML patients | AML patients in 1stCR |
|---|---|---|
Patients,no. | 48 | 40 |
Sex,male/female,no.(%) | 31(65)/17(35) | 24(60)/16(40) |
Median age,y(range) | 41(14–74) | 41(14–68) |
WBC count (10 9 /L) | ||
Median | 46.3 | 6.3 |
Range | 0.8-354.9 | 2.6-10.2 |
Hemoglobin (g/dL) | ||
Median | 7.7 | 11.8 |
Range | 4.1-13.2 | 8.3-16.1 |
Platelet count (10 9 /L) | ||
Median | 58 | 243.3 |
Range | 2-319 | 76-384 |
BM blasts (%) | ||
Median | 69.1 | 2.1 |
Range | (24–96) | (0–5) |
FAB subtype,n/(%) | ||
M2 | 9/(19) | 6/(15) |
M3 | 11/(23) | 20/(50) |
M4 | 11/(23) | 8/(20) |
M5 | 15/(31) | 5/(12.5) |
M6 | 2/(4) | 1/(2.5) |